Correlation Between Neuropace and Inspira Technologies

Can any of the company-specific risk be diversified away by investing in both Neuropace and Inspira Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Inspira Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuropace and Inspira Technologies Oxy, you can compare the effects of market volatilities on Neuropace and Inspira Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Inspira Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Inspira Technologies.

Diversification Opportunities for Neuropace and Inspira Technologies

-0.76

Correlation Coefficient

Neuropace  Inspira Technologies

Pay attention - limited upside

The 3 months correlation between Neuropace and Inspira is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Inspira Technologies Oxy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inspira Technologies Oxy and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Inspira Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inspira Technologies Oxy has no effect on the direction of Neuropace i.e., Neuropace and Inspira Technologies go up and down completely randomly.

Pair Corralation between Neuropace and Inspira Technologies

Given the investment horizon of 90 days Neuropace is expected to under-perform the Inspira Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Neuropace is 1.65 times less risky than Inspira Technologies. The stock trades about -0.04 of its potential returns per unit of risk. The Inspira Technologies Oxy is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  61.00  in Inspira Technologies Oxy on May 5, 2025 and sell it today you would earn a total of  62.00  from holding Inspira Technologies Oxy or generate 101.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Neuropace  vs.  Inspira Technologies Oxy

Neuropace

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neuropace has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in September 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Inspira Technologies Oxy

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Inspira Technologies Oxy are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Inspira Technologies displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neuropace and Inspira Technologies

The main advantage of trading using opposite Neuropace and Inspira Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Inspira Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspira Technologies will offset losses from the drop in Inspira Technologies' long position.

The idea behind Neuropace and Inspira Technologies Oxy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.